On June 21, 2017, Spotlight Innovation Inc. entered into a Sponsored Research Agreement with The Brigham and Women's Hospital Inc. to support research directed by BWH professor Kevin Hodgetts aimed at developing safe and effective drugs to treat patients with spinal muscular atrophy. The Company will provide to BWH an aggregate of $200,000 in funding support for the research project. The Company shall sponsor BWH's research project for a period of one year, unless sooner terminated by either party upon forty-five days advance written notice pursuant to the terms of the Agreement.